UPDATE : Tuesday, October 15, 2019
상단여백
Merck Korea forcefully shuts down general medicine biz by Kim Yun-mi 2019-10-15 15:51
Galderma Korea’s key strategy: choice and concentration by Kim Yun-mi 2019-10-15 13:56
Medytox, Daewoong still in dispute over Nabota's spore appraisal by Lee Han-soo 2019-10-15 11:28
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients by Lee Han-soo 2019-10-14 18:01
HanAll's Chinese partner ends P2 trial of dry eye treatment by Lee Han-soo 2019-10-14 14:08
라인
[Special] How are Korean employees coping with big-pharma M&As? by Kim Yun-mi 2019-10-14 13:45
Sanofi releases data showing improved survival for prostate cancer treatment by Lee Han-soo 2019-10-14 12:16
Regulator keeps Kolon Tissuegene listed with 1-year grace period by Lee Han-soo 2019-10-12 09:41
GC to market Merck's diabetes treatment by Lee Han-soo 2019-10-11 18:13
Bayer drugs out of stock in Korea by Lee Han-soo 2019-10-11 16:36
라인
Sanofi to cover part of Dupixent cost for atopic dermatitis patients by Kim Yun-mi 2019-10-11 15:13
Takeda Korea’s labor union goes on strike by Lee Han-soo 2019-10-11 14:33
Roche’s Tecentriq combo therapy shows encouraging results by Lee Han-soo 2019-10-10 17:36
Yuyu confirms safety of its antiplatelet drug by Lee Han-soo 2019-10-10 17:35
Doctors call Boehringer Ingelheim’s Jardiance marketing ‘unethical’ by Kim Yun-mi 2019-10-10 16:01
라인
FDA OKs AbbVie’s Hepatitis C drug to shorten treatment duration by Lee Han-soo 2019-10-08 18:04
Allergan Korea to replace breast implant without time limit by Lee Hye-seon 2019-10-08 15:22
Most of weight loss drug Saxenda irregularly distributed by Kwak Sung-sun 2019-10-08 15:19
Yuyang DNU, NSCI to develop treatment for dry macular degeneration by Lee Han-soo 2019-10-07 16:54
Sanofi confirms prolonged PFS in patients with advanced gastric cancer by Lee Han-soo 2019-10-07 14:39
여백
여백
여백
Back to Top